Introduction: The Question Posed by 'Momotaro' That No One KnowsWe all know the story of 'Momotaro' from a young age. Born ...
Incyte (Nasdaq:INCY) today announced that data from across its Inflammation and Autoimmunity (IAI) portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 2026, held ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that nearly 30 clinical studies of its globally first-in-class bispecific ...
Leaps' from the Perspective of Informational Epistemology and the Continuity of Life and Consciousness〉1. Humans do not ...
Urban Sales strikes deal with Les Valseurs Distribution to handle Ricardo Alves Jr.'s San Sebastián religious cult thriller ...
An effective strategy must connect three priorities: reducing risk, supporting care, and advancing treatment, says Paul Shemella.
“This multicenter real-world study suggests that first-line tislelizumab combined with platinum-etoposide chemotherapy provides encouraging efficacy with an acceptable safety profile in patients with ...
11h
David Gross, Nobel Prize in Physics: “The odds of humanity surviving another 50 years are very low”
The Nobel laureate spent decades probing the deepest laws of nature. Now his attention has turned to a far more immediate ...
Takeda ( TSE:4502/NYSE:TAK) announced that new data from its oncology pipeline and portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress, taking place October 23-27, ...
The ancient Egyptians built the pyramids with a height-to-base ratio of 1:1.618 — the Golden Ratio. The ancient Athenians, those masters of architecture, built the Parthenon with its column ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results